Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Applied Therapeutics stock (APLT)

Buy Applied Therapeutics stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Applied Therapeutics is a biotechnology business based in the US. Applied Therapeutics shares (APLT) are listed on the NASDAQ and all prices are listed in US Dollars. Applied Therapeutics employs 26 staff and has a market cap (total outstanding shares value) of 0.00.

Our top picks for where to buy Applied Therapeutics stock

Top pick for advanced traders

Go to site
Get up to $5,000 cash
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

Our pick for transfer bonus

Go to site
Get up to $10,000 cash
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options, with no options contract fees
  • No-cost financial planning and automated investing

Our pick for Investing by theme

Go to site
Earn up to $300 on new deposits
  • Trade $0 commission stocks & ETFs with as little as $1
  • Theme and ETF screener
  • Discover new opportunities with Opto's AI-driven classification system

How to buy Applied Therapeutics stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – APLT. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Applied Therapeutics stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
Tastytrade
Finder Score: 4.4 / 5: ★★★★★
Tastytrade
★★★★★
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Competitive, capped options commissions, with a reliable trading platform designed for serious traders.
SoFi Invest®
Finder Score: 4.2 / 5: ★★★★★
SoFi Invest®
★★★★★
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $10,000 cash
Commission-free stocks, ETFs and options, with no options per-contract fees. Plus, a no-cost robo-advisor and complimentary access to certified financial planners (CFPs).
OPTO
Finder Score: 3.1 / 5: ★★★★★
OPTO
★★★★★
Stocks, ETFs
$0
$0
N/A
Earn up to $300
AI-driven thematic investing, with proprietary research, fractional shares and commission-free stocks and ETFs.
Moomoo
Finder Score: 4.3 / 5: ★★★★★
Exclusive
Moomoo
★★★★★
Stocks, Options, ETFs
$0
$0
Up to 8.10%
Get up to 15 free stocks
No commission stock, ETF and options trades, with $0 equity options contract fees, low margin rates and advanced trading tools.
Public.com
Finder Score: 4.2 / 5: ★★★★★
Public.com
★★★★★
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
5.1%
Get up to $10,000 and transfer fees covered
Build a diversified portfolio of stocks, bonds, options, ETFs, crypto and alternative assets, with a high-yield cash account and options contract rebates.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Applied Therapeutics stock price (NASDAQ: APLT)

Use our graph to track the performance of APLT stocks over time.

Applied Therapeutics shares at a glance

Information last updated 2024-07-22.
Latest market close$5.14
52-week range$1.18 - $9.39
50-day moving average $4.68
200-day moving average $3.99
Wall St. target price$11.40
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.91

Is it a good time to buy Applied Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Applied Therapeutics price performance over time

Historical closes compared with the close of $5.14 from 2024-07-19

1 week (2024-07-16) -8.70%
1 month (2024-06-21) 12.97%
3 months (2024-04-23) 15.25%
6 months (2024-01-23) 90.37%
1 year (2023-07-21) 259.44%
2 years (2022-07-22) 420.77%
3 years (2021-07-23) 19.1
5 years (2019-07-23) 9.58

Applied Therapeutics financials

Gross profit TTM $0
Return on assets TTM -51.57%
Return on equity TTM -612.33%
Profit margin 0%
Book value $0.59
Market Capitalization $587.3 million

TTM: trailing 12 months

Applied Therapeutics share dividends

We're not expecting Applied Therapeutics to pay a dividend over the next 12 months.

Applied Therapeutics share price volatility

Over the last 12 months, Applied Therapeutics's shares have ranged in value from as little as $1.18 up to $9.39. A popular way to gauge a stock's volatility is its "beta".

APLT.US volatility(beta: 1.99)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied Therapeutics's is 1.992. This would suggest that Applied Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Applied Therapeutics overview

Applied Therapeutics, Inc. , a clinical-stage biopharmaceutical company, engages in the development of a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need in the United States. The company's lead product candidate is AT-007 (also called govorestat) that has completed phase 3 for the treatment of galactosemia in healthy volunteers and adults, in pediatric clinical study for the treatment of galactosemia in kids, for treating enzyme sorbitol dehydrogenase, and for the treatment of phosphomannomutase enzyme-CDG. It also develops AT-001 (also called caficrestat) that is in phase 3 clinical trials to treat diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy; and AT-003, which is in preclinical studies for the treatment diabetic retinopathy. The company has exclusive license and supply agreement with Mercury Pharma Group Limited to commercialize drug products containing AT-007. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Frequently asked questions

null
What percentage of Applied Therapeutics is owned by insiders or institutions?
Currently 5.951% of Applied Therapeutics shares are held by insiders and 87.712% by institutions.
How many people work for Applied Therapeutics?
Latest data suggests 26 work at Applied Therapeutics.
When does the fiscal year end for Applied Therapeutics?
Applied Therapeutics's fiscal year ends in December.
Where is Applied Therapeutics based?
Applied Therapeutics's address is: 545 Fifth Avenue, New York, NY, United States, 10017
What is Applied Therapeutics's ISIN number?
Applied Therapeutics's international securities identification number is: US03828A1016
What is Applied Therapeutics's CUSIP number?
Applied Therapeutics's Committee on Uniform Securities Identification Procedures number is: 03828A101

More guides on Finder

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site